Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 65, Issue 5-6, 2001, Pages 241-246

  Milochevitch, C ^a   Khalil, A ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSHOCHOLINE ESTERASE; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN; PARAOXON; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; OXIDATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

EID: 0035726253     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0320     Document Type: Article

References (38)

1. Low density lipoprotein oxidation and its pathobiological significance
2. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit
3. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio
4. HDL, its enzymes and its potential to influence lipid peroxidation
5. Age-related development of atherosclerotic plaque stress: A population-based finite-element analysis
6. The older man's heart and heart disease
7. GIn-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
8. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1 (192) or PON1 (55) genotype
9. Serum paraoxonase after myocardial infarction
10. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes
11. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase
12. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein
13. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor
14. Decrease of serum paraoxonase activity in chronic renal failure
15. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
16. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
17. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
18. Emerging evidence for inflammation in conditions frequently affecting older adults: Report of a symposium
19. Transcription factors and age-related decline in apolipoprotein A-I expression
20. Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3
21. Cardiovascular survey methods
22. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence
23. Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation
24. Protein purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
25. The human serum paraoxonase polymorphism: Identification of phenotypes by their response to salts
26. The human serum paraoxonase/arylesterase polymorphism
27. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL
28. Increased susceptibility of low-density lipoprotein (LDL) to oxidation by gamma-radiolysis with age
29. Age-related increased susceptibility of high-density lipoproteins (HDL) to in-vitro oxidation induced by gamma-radiolysis of water
30. Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins
31. Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure
32. Are Canadian Inuit at increased genetic risk for coronary heart disease?
33. Alterations of antioxidant enzymes and oxidative stress markers in aging
34. Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin
35. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
36. Effects of age and physical performance capacity on distribution and composition of high-density lipoprotein subfractions in men
37. Paraoxonase and atherosclerosis
38. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis